1. Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies
   Jun He et al, 2024, MedComm CrossRef
2. Novel antibody-drug conjugates based on DXd-ADC technology
   Rong Chen et al, 2024, Bioorganic Chemistry CrossRef
3. Chemotherapy Induced Corneal Changes Assessed by Corneal Confocal Microscopy: A Review
   Eleonora Cosmo et al, 2024, Diagnostics CrossRef
4. Mechanisms of resistance of antibody-drug conjugates—Obstacles to overcome
   Yanitsa Davidkova et al, 2025, Resistance in Hematologic Malignancies and Cancer CrossRef
5. Design, synthesis and bioactivity evaluation of novel monomethyl auristatin F analogues
   Lisheng Yang et al, 2024, Molecular Diversity CrossRef
6. Moderne Immuntherapie: Update zu Antikörper-Wirkstoff-Konjugaten bei hämatologischen Neoplasien
   Maximilian Steinhardt et al, 2023, Trillium Krebsmedizin CrossRef
7. Economics of Antibody Drug Conjugates (ADCs): Innovation, Investment and Market Dynamics
   Arya Bhushan et al, 2024, Current Oncology Reports CrossRef
8. The Fundamental Role of Oxime and Oxime Ether Moieties in Improving the Physicochemical and Anticancer Properties of Structurally Diverse Scaffolds
   Jean Fotie et al, 2023, International Journal of Molecular Sciences CrossRef